TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31278785

Group type: EXPERIMENTAL
Intervention: everolimus (r‐ATG/EVR)
Number of subjects: 171

Group type: COMPARATOR
Intervention: mycophenolate (r‐ATG/MPS)
Number of subjects: 171
Study: 28454511

Group type: EXPERIMENTAL
Intervention: Percutaneous laser disc decompression
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 115
Study: 27744141

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg every 4 weeks plus DMARDs)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo (every 4 weeks plus DMARDs)
Number of subjects: 357
Study: 25623430

Group type: EXPERIMENTAL
Intervention: Antigen carbohydrate 125-guided therapy
Number of subjects: 383

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 383
Study: 21777054

Group type: EXPERIMENTAL
Intervention: Ready-to-eat cereal (RTEC) consumed instead of normal evening snack for 6 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal evening snack (control group)
Number of subjects: 70
Study: 20456867

Group type: EXPERIMENTAL
Intervention: Arrival index for cortisol
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Arrival index for alpha-amylase
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Arrival index for cortisol and alpha-amylase
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Magnitude of difference in cortisol and alpha-amylase between arrival and 1h after arrival
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Self-reported anxiety
Number of subjects: 88
Study: 18072367

Group type: EXPERIMENTAL
Intervention: Physical activity promotion intervention
Number of subjects: 61
Study: 16037107

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol moistened with 3 ml of 5% acetic acid (group A, n = 33)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intravaginal misoprostol moistened with 3 ml of saline (group B, n = 33)
Number of subjects: 66
Study: 12074357

Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of Candesartan 16 mg and Felodipine 5 mg
Number of subjects: 31
Study: 10583039

Group type: EXPERIMENTAL
Intervention: Grape juice (200 ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (200 ml)
Number of subjects: 12
Study: 7671980

Group type: EXPERIMENTAL
Intervention: Myotonic patients
Number of subjects: 14
Study: 2402215

Group type: EXPERIMENTAL
Intervention: CAPE training (N = 15)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (N = 14)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (N = 14)
Number of subjects: 43
Study: 6308970

Group type: EXPERIMENTAL
Intervention: Intensive aftercare recruitment procedure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular clinic aftercare
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (intensive and regular aftercare)
Number of subjects: 50
Study: 30666826

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 797

Group type: COMPARATOR
Intervention: Placebo (switched to tofacitinib at month 3 or 6)
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg or 10 mg twice daily plus MTX
Number of subjects: 797
Study: 29936695

Group type: EXPERIMENTAL
Intervention: Hypofractionated accelerated radiotherapy (HART)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (CRT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both HART and CRT
Number of subjects: 89
Study: 26969758

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (Zilver PTX)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Provisional Paclitaxel-eluting stent (Zilver PTX)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Standard care (PTA and provisional Zilver bare metal stent)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Provisional bare metal stent (BMS)
Number of subjects: 474
Study: 25163948

Group type: EXPERIMENTAL
Intervention: Micro-hip approach (n=55)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Bauer approach (n=88)
Number of subjects: 143
Study: 22285454

Group type: EXPERIMENTAL
Intervention: Vocal counseling procedure
Number of subjects: 154

Group type: COMPARATOR
Intervention: No vocal counseling procedure
Number of subjects: 154
Study: 19057387

Group type: EXPERIMENTAL
Intervention: Whole milk intake (highest vs. lowest quintile)
Number of subjects: 26556

Group type: EXPERIMENTAL
Intervention: Yogurt intake (highest vs. lowest quintile)
Number of subjects: 26556

Group type: EXPERIMENTAL
Intervention: Cream intake (highest quintile)
Number of subjects: 26556

Group type: COMPARATOR
Intervention: Total dairy, low-fat milk, sour milk, cheese, ice cream, butter intake
Number of subjects: 26556
Study: 20517331

Group type: EXPERIMENTAL
Intervention: Alpha-lactalbumin-enriched and probiotic-supplemented formula (EF, Modilac Digest 1)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control formula (CF)
Number of subjects: 66
Study: 16137239

Group type: EXPERIMENTAL
Intervention: High-grade mobilisation techniques
Number of subjects: 92

Group type: COMPARATOR
Intervention: Low-grade mobilisation techniques
Number of subjects: 92
Study: 12171373

Group type: EXPERIMENTAL
Intervention: Social skills training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care or other active interventions
Number of subjects: 0
Study: 9610927

Group type: EXPERIMENTAL
Intervention: 4% BCAA solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: 4% amino acid solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ringers lactate
Number of subjects: 6
Study: 7821128

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Sulfonylurea (glyburide, G)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Combination therapy (M/G, G/M, MGH)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 144

Group type: COMPARATOR
Intervention: Single-drug therapy (M or G)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Low-dose primary combination (MGL)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Glyburide alone (G)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Metformin alone (M)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Combination therapy (M and G)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Overall drug safety
Number of subjects: 144
Study: 3270508

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (500 mg orally every 4 hours for 3 days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Etoposide (100 mg/m2 per day by continuous infusion for 3 days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of hydroxyurea and etoposide (fixed molar ratio of 58.9:1)
Number of subjects: 19
Study: 29782049

Group type: EXPERIMENTAL
Intervention: ADAM zolmitriptan 3.8 mg
Number of subjects: 159
Study: 27345843

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 180

Group type: COMPARATOR
Intervention: Non-cetuximab
Number of subjects: 180
Study: 24534036

Group type: EXPERIMENTAL
Intervention: N alpha methyl histamine (1 to 3 ug twice a week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propranolol (120 mg/day)
Number of subjects: 60
Study: 22382047

Group type: EXPERIMENTAL
Intervention: Sit-Up Test (orthostatic challenge)
Number of subjects: 49
Study: 23437548

Group type: EXPERIMENTAL
Intervention: Vaccine candidate (live attenuated oral Vibrio cholerae Ol El Tor, Ogawa strain 638)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Vaccine candidate
Number of subjects: 21
Study: 18522501

Group type: EXPERIMENTAL
Intervention: Inactivated vaccine
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Live attenuated vaccine
Number of subjects: 2058

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2058
Study: 15681602

Group type: EXPERIMENTAL
Intervention: Radiotherapy + Endocrine Therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Endocrine Therapy Alone
Number of subjects: 200
Study: 15526517

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10641740

Group type: EXPERIMENTAL
Intervention: Ozone exposure (0.4 ppm during 2 h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ozone exposure (after second exposure)
Number of subjects: 16
Study: 9345414

Group type: EXPERIMENTAL
Intervention: Cladribine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1711156

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 6369527

Group type: EXPERIMENTAL
Intervention: Positive pressure breathing (0.4 kPa)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Mouthpiece and face mask without positive pressure
Number of subjects: 7
Study: 30921650

Group type: EXPERIMENTAL
Intervention: ISO‐SINGJT reference task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ISO‐CYC reference task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isovelocity sprint cycling test (120 RPM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoinertial acceleration sprint cycling test (0 to >150 RPM)
Number of subjects: 0
Study: 29722727

Group type: EXPERIMENTAL
Intervention: Fresh specimens assessed by raters including surgeons, pathologists, pathology residents, pathologists' assistants, and pathologists' assistant trainees.
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Postfixation specimens assessed by pathologists and pathologists' assistants.
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Pathologists' assistants grading specimens postfixation.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison of agreement between different rater groups.
Number of subjects: 37
Study: 27608067

Group type: EXPERIMENTAL
Intervention: Extended practice without aids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External aids combined with extended practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External aids with limited practice and instructions removing perceived memory requirements
Number of subjects: 0
Study: 24491075

Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Support Group (SG)
Number of subjects: 115
Study: 22959881

Group type: EXPERIMENTAL
Intervention: Topical prednisolone phosphate 1%
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 21149918

Group type: EXPERIMENTAL
Intervention: Once-daily lamivudine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Once-daily abacavir
Number of subjects: 41

Group type: COMPARATOR
Intervention: Twice-daily lamivudine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Twice-daily abacavir
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Once-daily lamivudine and abacavir
Number of subjects: 41
Study: 17482560

Group type: EXPERIMENTAL
Intervention: State guilt induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: State anxiety induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral affect induction
Number of subjects: 0
Study: 16597777

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 11254911

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: No lipid lowering therapy
Number of subjects: 62
Study: 9647153

Group type: EXPERIMENTAL
Intervention: Diclofenac (100 mg suppositories)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8090921

Group type: EXPERIMENTAL
Intervention: Gadoteridol at standard dose (0.1 mmol/kg)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Gadoteridol at triple dose (0.3 mmol/kg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Both doses of gadoteridol
Number of subjects: 95
Study: 2531389

Group type: EXPERIMENTAL
Intervention: Propranolol therapy (n = 26 after exclusions)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Surgery (ligation of the esophagus on clip) (n = 24 after exclusions)
Number of subjects: 55
Study: 1097489

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 159

Group type: COMPARATOR
Intervention: Phenylbutazone-alka
Number of subjects: 159
Study: 31815981

Group type: EXPERIMENTAL
Intervention: Piezocision‐assisted orthodontics
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional orthodontics
Number of subjects: 20
Study: 31654994

Group type: EXPERIMENTAL
Intervention: LISA (n=83)
Number of subjects: 129

Group type: COMPARATOR
Intervention: INSURE (n=46)
Number of subjects: 129
Study: 28917695

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 0
Study: 25819139

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 1441
Study: 23723278

Group type: EXPERIMENTAL
Intervention: Operative treatment (fixation of the clavicular fracture)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 25
Study: 21842003

Group type: EXPERIMENTAL
Intervention: 1-stage early loaded implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2-stage early loaded implants
Number of subjects: 30
Study: 19570389

Group type: EXPERIMENTAL
Intervention: Endovenous radiofrequency ablation combined with TriVex
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional stripping operation combined with TriVex
Number of subjects: 150
Study: 17943677

Group type: EXPERIMENTAL
Intervention: Remote administration of the Functional Reach Test (FRT)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Remote administration of the European Stroke Scale (ESS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Face-to-face administration of the Functional Reach Test (FRT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Face-to-face administration of the European Stroke Scale (ESS)
Number of subjects: 26
Study: 15257995

Group type: EXPERIMENTAL
Intervention: Continuous, 60-Hz nighttime magnetic field exposure (0.5-1.0 micro T above ambient levels)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ambient magnetic field levels (0.001-0.50 micro T)
Number of subjects: 0
Study: 11340701

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate (BDP) 400 micrograms/day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 9272245

Group type: EXPERIMENTAL
Intervention: Estradiol transdermal patch (Dermestril) with 25 micrograms/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Estradiol transdermal patch (Dermestril) with 50 micrograms/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Estradiol transdermal patch (Dermestril) with 100 micrograms/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Estradiol transdermal patch (Dermestril)
Number of subjects: 24
Study: 8409874

Group type: EXPERIMENTAL
Intervention: Computerized medical record system with voice input
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Computerized medical record system with keyboard input
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard paper-and-pencil charting system
Number of subjects: 3
Study: 3485521

Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 30875684

Group type: EXPERIMENTAL
Intervention: Surgery for recurrent lumbar disc herniation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (31 healthy subjects)
Number of subjects: 24
Study: 26932835

Group type: EXPERIMENTAL
Intervention: 6-PACK programme
Number of subjects: 8877

Group type: EXPERIMENTAL
Intervention: Preimplementation studies
Number of subjects: 8877

Group type: EXPERIMENTAL
Intervention: Implementation plan
Number of subjects: 8877
Study: 24618266

Group type: EXPERIMENTAL
Intervention: MTX+ETN
Number of subjects: 110

Group type: COMPARATOR
Intervention: MTX+PBO
Number of subjects: 110
Study: 21920711

Group type: EXPERIMENTAL
Intervention: SSRI monotherapy (escitalopram plus placebo)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Combination antidepressant medication (bupropion-sustained release plus escitalopram or venlafaxine-extended release plus mirtazapine)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Baseline depressive severity
Number of subjects: 665
Study: 19191775

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Fluticasone proprionate nasal drops (FPND) 400 microg b.i.d.
Number of subjects: 68
Study: 17927437

Group type: EXPERIMENTAL
Intervention: Eight speech enhancement methods (four classes of algorithms: spectral subtractive, sub-space, statistical model based, and Wiener-type algorithms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subspace algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall analysis of consonant confusion matrices
Number of subjects: 0
Study: 15309376

Group type: EXPERIMENTAL
Intervention: LY354740 (100 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: LY354740 (400 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 19
Study: 14641843

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ivermectin (IVM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10389719

Group type: EXPERIMENTAL
Intervention: 10-cm2 patch of 0.025 mg estradiol and 0.125 mg norethisterone acetate
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: 20-cm2 patch of 0.05 mg estradiol and 0.25 mg norethisterone acetate
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Oral HRT (2 mg estradiol and 1 mg norethisterone acetate)
Number of subjects: 441
Study: 8876026

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 0
Study: 1496227

Group type: EXPERIMENTAL
Intervention: Lumpectomy and local breast irradiation (LXRT)
Number of subjects: 488
Study: 6651519

Group type: EXPERIMENTAL
Intervention: Cimetidine (maintained regimen)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cimetidine (stopped 6 hours before surgery)
Number of subjects: 20
Study: 3511932

Group type: EXPERIMENTAL
Intervention: Prilocaine plus potassium chloride
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus potassium chloride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prilocaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 20
Study: 31758571

Group type: EXPERIMENTAL
Intervention: Sequential therapy (10 days of rabeprazole, clarithromycin, amoxycillin, and tinidazole; 60 pills, cost US$10)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Concomitant therapy (14 days of rabeprazole, clarithromycin, amoxycillin, and tinidazole; 140 pills, cost US$23)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 313

Group type: COMPARATOR
Intervention: Concomitant therapy
Number of subjects: 313
Study: 29665833

Group type: EXPERIMENTAL
Intervention: Bioactive vitamin D (calcitriol) added to RAAS inhibition treatment using ACEI or ARB
Number of subjects: 320
Study: 28498184

Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Facility Peer Support
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Community Peer Support
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: ART failure (HIVRNA ≥1000 copies/ml)
Number of subjects: 1269
Study: 25748549

Group type: EXPERIMENTAL
Intervention: Exercise programme (six sessions of strengthening and stretching exercises with a hand therapist, daily home exercises)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Usual care (joint protection education, general exercise advice, functional splinting if required)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Exercise programme
Number of subjects: 490
Study: 23032305

Group type: EXPERIMENTAL
Intervention: Caloric restriction + resistance training (CRRT)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 127
Study: 20204491

Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling delivered by nurses
Number of subjects: 273
Study: 18067975

Group type: EXPERIMENTAL
Intervention: Medication (tianeptine or fluoxetine) + Psychotherapy (supportive, cognitive-behavioral, or psychodynamic)
Number of subjects: 649
Study: 16758107

Group type: EXPERIMENTAL
Intervention: Conventional standing postero-anterior full spine radiograph (n=53)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Digital storage phosphor plate system (CR) (n=48)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Digital pulsed fluoroscopy (n=49)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional films (control group)
Number of subjects: 150
Study: 12676739

Group type: COMPARATOR
Intervention: Furosemide (40 mg, orally) with placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg, orally) with losartan (50 mg, orally)
Number of subjects: 10
Study: 11099170

Group type: EXPERIMENTAL
Intervention: Exercise test after 24 hours recovery
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise test after 48 hours recovery
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise test after 72 hours recovery
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise test after 96 hours recovery
Number of subjects: 48
Study: 8831526

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 42
Study: 1506604

Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in late pregnant women
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in nonpregnant women
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 100 g glucose ingestion in early pregnant women
Number of subjects: 45